Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 179

1.

Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods.

Marino F, Schembri L, Rasini E, Pinoli M, Scanzano A, Luini A, Congiu T, Cosentino M.

J Immunol Methods. 2017 Feb 3. pii: S0022-1759(16)30312-X. doi: 10.1016/j.jim.2017.01.013. [Epub ahead of print]

PMID:
28167274
2.

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease.

Comi C, Ferrari M, Marino F, Magistrelli L, Cantello R, Riboldazzi G, Bianchi ML, Bono G, Cosentino M.

Int J Mol Sci. 2017 Jan 24;18(2). pii: E242. doi: 10.3390/ijms18020242.

3.

β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.

Coelho M, Soares-Silva C, Brandão D, Marino F, Cosentino M, Ribeiro L.

J Cancer Res Clin Oncol. 2017 Feb;143(2):275-291. doi: 10.1007/s00432-016-2278-1. Review.

PMID:
27709364
4.

Dataset of mRNA levels for dopaminergic receptors, adrenoceptors and tyrosine hydroxylase in lymphocytes from subjects with clinically isolated syndromes.

Cosentino M, Zaffaroni M, Legnaro M, Bombelli R, Schembri L, Baroncini D, Bianchi A, Clerici R, Guidotti M, Banfi P, Bono G, Marino F.

Data Brief. 2016 Sep 17;9:376-381.

5.

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.

Kustrimovic N, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Comi C, Mauri M, Minafra B, Riboldazzi G, Sanchez-Guajardo V, Marino F, Cosentino M.

Sci Rep. 2016 Sep 22;6:33738. doi: 10.1038/srep33738.

6.

Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis.

Cosentino M, Zaffaroni M, Legnaro M, Bombelli R, Schembri L, Baroncini D, Bianchi A, Clerici R, Guidotti M, Banfi P, Bono G, Marino F.

J Neuroimmunol. 2016 Sep 15;298:82-9. doi: 10.1016/j.jneuroim.2016.07.008.

PMID:
27609280
7.

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Ferrari M, Comi C, Marino F, Magistrelli L, De Marchi F, Cantello R, Riboldazzi G, Bono G, Cosentino M.

Eur J Clin Pharmacol. 2016 Nov;72(11):1335-1341.

PMID:
27497990
8.
9.

Anti-inflammatory effects exerted by Killox®, an innovative formulation of food supplement with curcumin, in urology.

Cosentino V, Fratter A, Cosentino M.

Eur Rev Med Pharmacol Sci. 2016 Apr;20(7):1390-8.

10.

Surgical treatment of Peyronie's disease with small intestinal submucosa graft patch.

Cosentino M, Kanashiro A, Vives A, Sanchez J, Peraza MF, Moreno D, Perona J, De Marco V, Ruiz-Castañe E, Sarquella J.

Int J Impot Res. 2016 May;28(3):106-9. doi: 10.1038/ijir.2016.10.

PMID:
27030055
11.

Multiple sclerosis: Repurposing dopaminergic drugs for MS--the evidence mounts.

Marino F, Cosentino M.

Nat Rev Neurol. 2016 Apr;12(4):191-2. doi: 10.1038/nrneurol.2016.33. No abstract available.

PMID:
27020558
12.

Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy.

Loraschi A, Bellantonio P, Bortolon F, Capra R, Cavalla P, Costantino G, Lugaresi A, Martinelli V, Marrosu MG, Patti F, Rottoli M, Salvetti M, Sola P, Solaro C, Klersy C, Marino F, Zaffaroni M, Cosentino M.

Neurol Sci. 2016 Apr;37(4):613-22. doi: 10.1007/s10072-016-2519-8.

PMID:
26895323
13.

Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment.

Guasti L, Maresca AM, Schembri L, Rasini E, Dentali F, Squizzato A, Klersy C, Robustelli Test L, Mongiardi C, Campiotti L, Ageno W, Grandi AM, Cosentino M, Marino F.

BMC Cardiovasc Disord. 2016 Jan 29;16:26. doi: 10.1186/s12872-016-0201-y.

14.

Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity.

Leite F, Lima M, Marino F, Cosentino M, Ribeiro L.

PLoS One. 2016 Jan 25;11(1):e0147483. doi: 10.1371/journal.pone.0147483.

15.

The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications.

Cosentino M, Marino F.

J Neuroimmune Pharmacol. 2016 Mar;11(1):214-26. doi: 10.1007/s11481-015-9649-2.

PMID:
26670166
16.

Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors.

Zanella S, Mingozzi M, Dal Corso A, Fanelli R, Arosio D, Cosentino M, Schembri L, Marino F, De Zotti M, Formaggio F, Pignataro L, Belvisi L, Piarulli U, Gennari C.

ChemistryOpen. 2015 Oct;4(5):633-41. doi: 10.1002/open.201500062.

17.

Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects.

Cosentino M, Ferrari M, Kustrimovic N, Rasini E, Marino F.

Hum Immunol. 2015 Oct;76(10):747-52. doi: 10.1016/j.humimm.2015.09.032.

PMID:
26429319
18.

Adrenergic regulation of innate immunity: a review.

Scanzano A, Cosentino M.

Front Pharmacol. 2015 Aug 13;6:171. doi: 10.3389/fphar.2015.00171. Review.

19.

Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives.

Cosentino M, Marino F, Maestroni GJ.

Front Cell Neurosci. 2015 Aug 5;9:302. doi: 10.3389/fncel.2015.00302. Review.

20.

Bladder cancer diagnosis: the role of CT urography.

Capalbo E, Kluzer A, Peli M, Cosentino M, Berti E, Cariati M.

Tumori. 2015 Jul-Aug;101(4):412-7. doi: 10.5301/tj.5000331.

PMID:
25953449
Items per page

Supplemental Content

Loading ...
Support Center